<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164892">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02015897</url>
  </required_header>
  <id_info>
    <org_study_id>S-20130091</org_study_id>
    <nct_id>NCT02015897</nct_id>
  </id_info>
  <brief_title>Effect of Physical Therapy on Breast Cancer Related Lymphedema</brief_title>
  <official_title>Effect of Physical Therapy on Breast Cancer Related Lymphedema; A Multicenter, Randomized, Single-blind, Equivalence Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital of South West Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital of South West Denmark</source>
  <oversight_info>
    <authority>Denmark: Ethics Committee</authority>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate if Complete Decongestive Therapy  is equally
      effective whether it includes manual lymphatic drainage or not in the treatment of
      lymphoedema among patients with breast cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Physical therapy treatment of patients with lymphoedema includes treatment based on the
      principles of 'Complete Decongestive Therapy' (CDT). CDT consists of following components;
      skin care, manual lymphatic drainage, bandaging and exercises. Regarding what type of
      treatment of treatments is most effective, the scientific evidence is sparse. Studies have
      focused on the time-consuming manual lymphatic drainage, but the scientific evidence is not
      consistent.

      A randomized, single-blind, equivalence trial. A total of 160 breast cancer patients with
      lymphoedema will be recruited from 3 hospitals and randomised into one of two treatment
      groups:  A: Complete Decongestive TherapyA (incl. manual drainage) or B: Complete
      Decongestive TherapyB (except manual lymphatic drainage
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The percentage volume reduction of lymphoedema (%)</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in circumference of the arm (composite outcome measure), bodyweight, patient sensation of heaviness, patient sensation of tension, and quality of life</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Circumference of the arm consists of 7 measurements but these will be converted to one outcome measure when estimating the difference between baseline and post intervention measurements</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage volume reduction of lymphedema (%) from baseline to week 4. Percentage volume reduction of lymphedema (%) from week 4 to week 7</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Lymphoedema</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Physical TherapyB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical TherapyA</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group A</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physical TherapyA</intervention_name>
    <description>Group A:
Skin care
Manual lymphatic drainage
Bandaging using Coban™2Lite
Guidance on physical activity</description>
    <arm_group_label>Physical TherapyB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physical TherapyB</intervention_name>
    <description>Group B:
Skin care
Bandaging using Coban™2Lite
Guidance on physical activity</description>
    <arm_group_label>Physical TherapyA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The diagnose breast cancer regardless of date for operation and identified
             lymphoedema

          -  Precede ultrasonic scanning of axilla in order to exclude local relapse

          -  Lymphoedema &gt; 2 cm i.e. stage  II-III

          -  Completed radiotherapy and/or chemotherapy at least 2 months prior inclusion

        Exclusion Criteria:

          -  Relapse of breast cancer

          -  Untreated infection

          -  Untreated heart failure

          -  Untreated renal failure

          -  Untreated deep venous thrombosis in the arm

          -  Unable to participate in physiotherapy treatment and/or not able to understand
             instructions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bibi Gram, PhD</last_name>
    <role>Study Director</role>
    <affiliation>THe Hospital of Southwest Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Physical Therapy, Hospital of Southern Jutland</name>
      <address>
        <city>Aabenraa</city>
        <state>Region of Southern Denmark</state>
        <zip>6200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bibi Gram, PhD</last_name>
      <phone>+4579182356</phone>
      <email>bgram@health.sdu.dk</email>
    </contact>
    <investigator>
      <last_name>Bettina Michelsen, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Southwest Denmark</name>
      <address>
        <city>Esbjerg</city>
        <state>Region of Southern Denmark</state>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bibi Gram, PhD</last_name>
      <phone>+4579182356</phone>
      <email>bgram@health.sdu.dk</email>
    </contact>
    <investigator>
      <last_name>Mette Tambour, PT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Physical Therapy, Lillebaelt Hospital</name>
      <address>
        <city>Vejle</city>
        <state>Region of Southern Denmark</state>
        <zip>7000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bibi Gram, PhD</last_name>
      <phone>+4579182356</phone>
      <email>bgram@health.sdu.dk</email>
    </contact>
    <investigator>
      <last_name>Kirsten Joens, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.sydvestjysksygehus.dk</url>
    <description>Link to the Hospital of Southwest Denmark</description>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital of South West Denmark</investigator_affiliation>
    <investigator_full_name>Bibi Gram</investigator_full_name>
    <investigator_title>PostDoc, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
